Human Milk Oligosaccharides (HMO) Market Predicted to Grow at a CAGR of 24.6% from 2023 to 2031 | Abbott, Inbiose, Glycom

Human Milk Oligosaccharides (HMO) Market 2025 Opportunities and Growth Size -

The global Human Milk Oligosaccharides (HMO) market was valued at US$ 708 million in 2024 and is anticipated to reach US$ 3225 million by 2031, witnessing a CAGR of 24.6% during the forecast period 2025-2031. This revolutionary Market Research Report dives deep into the essence of the Maize Bran sector, unraveling its significance and its transformative role in various industries. This comprehensive report is set to guide professionals in the art of deciphering market dynamics, unlocking the potential for informed decisions and strategic excellence.

Download Exclusive PDF Sample: (Including Full TOC, Data Tables, Visual Charts) @ https://qyresearch.in/request-sample/food-beverages-global-human-milk-oligosaccharides-hmo-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031

Human Milk Oligosaccharides (HMO) are a class of complex carbohydrates naturally found in human breast milk. They are composed of multiple sugar units linked by glycosidic bonds. HMOs are one of the most abundant components in human milk after fat, protein, and lactose, and their concentration is significantly higher in human milk compared to other mammals. HMOs play a crucial role in infant health, serving as prebiotics that promote the growth of beneficial bacteria, such as bifidobacteria, helping to establish a healthy gut microbiome and enhance immune system function.

HMOs vary in structure, including monosaccharides, disaccharides, trisaccharides, and longer polysaccharide chains. Different types of HMOs have distinct biological functions, helping to combat pathogen invasion, reduce inflammation, and support brain development. While HMOs are primarily found in human milk, advances in technology have made it possible to extract and synthesize these oligosaccharides through fermentation and chemical processes for use in commercial products like infant formula, functional foods, and health supplements.

With ongoing research into the benefits of HMOs in infant health and other wellness applications, the demand for human milk oligosaccharides has been steadily increasing, particularly in infant formula and adult prebiotic foods.

Top Market Players

According to the QY Research report, leading global companies in the Human Milk Oligosaccharides (HMO) market include:

Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem

Companies are selected based on parameters such as: -

> Revenue generation
> Manufacturing facilities
> R&D investments
> Market share and innovation pipeline
> Geographical presence

Market Drivers and Barriers:-

As consumer awareness of health increases, especially in regard to infant health, the market for human milk oligosaccharides (HMOs) is experiencing significant growth opportunities. In recent years, extensive research on the role of HMOs in infant health has led more infant formula manufacturers to incorporate HMOs into their products to support immune function and gut health. Additionally, HMOs have shown potential in adult health applications, particularly in maintaining gut microbiome balance and enhancing immune function, opening new growth avenues for the market. As the global population ages and the demand for functional foods rises, there is also growing demand for prebiotic products targeting adults.

Global Human Milk Oligosaccharides (HMO) Market Demand and Trend:

The downstream demand for HMOs is mainly concentrated in infant formula, prebiotic foods and supplements, and personalized nutrition products. As consumers increasingly demand personalized and functional nutrition products, the market for HMOs as a functional ingredient will continue to grow. Additionally, the potential for HMOs in aging populations is being recognized, particularly for supporting gut health and immune systems in elderly individuals.

Market Risks:

Despite the promising outlook for the HMO market, there are several risks. First, the production of HMOs is complex and costly, which may hinder product accessibility and price competitiveness. Second, the HMO supply chain is intricate, involving multiple stages such as raw material extraction and fermentation. Any technological challenges or disruptions in production could affect the stability of the entire supply chain. Moreover, global regulatory and standard differences may pose challenges to market expansion, particularly in terms of varying regulatory policies and certification requirements in different countries.

Market Concentration:

Currently, the HMO production market is relatively concentrated, with several leading biotech and pharmaceutical companies dominating the industry. These companies have advanced fermentation and biosynthesis technologies that enable large-scale production while maintaining high quality. However, as technology advances and the market expands, more small and medium-sized enterprises are expected to enter the market, fostering competition and innovation.

Detailed of Human Milk Oligosaccharides (HMO) Market Segmentation: -

Our market analysts are experts in deeply segmenting the global Human Milk Oligosaccharides (HMO) market and thoroughly evaluating the growth potential of each and every segment studied in the report. Right at the beginning of the research study, the segments are compared on the basis of consumption and growth rate for a review period of nine years. The segmentation study included in the report offers a brilliant analysis of the global Human Milk Oligosaccharides (HMO) market, taking into consideration the market potential of different segments studied. It assists market participants to focus on high-growth areas of the global Human Milk Oligosaccharides (HMO) market and plan powerful business tactics to secure a position of strength in the industry.

Segmentation By Type :-

2'-FL & 3-FL
LNT & LNnT, etc.

Segmentation By Application : -

Infant Formula
Others

Regional Insights -

United States

Canada
Mexico
Brazil
China

APAC

Japan
South Korea
China
ASEAN
India

EMEA

Europe
Middle East
Africa

Request for Pre-Order Enquiry On This Exclusive Report @ https://qyresearch.in/pre-order-inquiry/food-beverages-global-human-milk-oligosaccharides-hmo-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031

Each chapter in the report delivers a wealth of information:

ᗒ Product Definitions, Types, and Volume/Revenue Analysis

ᗒ Manufacturer Competition Status

ᗒ Historical and Forecast Volume/Revenue Analysis

ᗒ Product Application Analysis

ᗒ Country-Level Analysis

ᗒ Manufacturer Profiles

ᗒ Industry Chain Insights

ᗒ Market Channel, Distributors, and Customers

ᗒ Conclusive Remarks

ᗒ Methodology and Data Sources

Key Features Of The Study:-

ᗒ This report provides in-depth analysis of the global Human Milk Oligosaccharides (HMO) market, and provides market size (us$ million) and cagr for the forecast period (205-2031), considering 2023 as the base year.

ᗒ This report profiles key players in the global Human Milk Oligosaccharides (HMO) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Milk Oligosaccharides (HMO) sales data, market share and ranking.

ᗒ This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

ᗒ This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

ᗒ The global Human Milk Oligosaccharides (HMO) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Important questions answered in the report includes of:

ᗒ How will the market for the Human Milk Oligosaccharides (HMO) Market industry grow in 2025?

ᗒ Which well-known major companies will drive the market's growth?

ᗒ Which size of business held the biggest market share for data centre?

ᗒ What is the market's Compound Annual Growth Rate (CAGR) for the 2025-2031 forecast period?

ᗒ What is the primary factor driving the market's expansion?

ᗒ In the market, which region held the highest market share?

Related Reports You May Be Interested In:

https://qyresearch.in/report-details/1305698/Global-Inhalation-Therapy-Nebulizer-Market-Insights

https://qyresearch.in/report-details/9065843/Global-Low-Dielectric-Resin-Market-Insights

https://qyresearch.in/report-details/0281754/Global-PCR-Machine-Market-Insights

https://qyresearch.in/report-details/8190264/Global-Photocatalytic-Coatings-Market-Insights

https://qyresearch.in/report-details/8190264/Global-Photocatalytic-Coatings-Market-Insights

Contact Us:

QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - arshad@qyrindia.com
Web - https://www.qyresearch.in

About Us:

QYResearch established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

This release was published on openPR.